COVID-19 engagement restrictions brought Digital Thought Leaders (DTLs) to the spotlight. In response, many biopharma companies worked vigorously to first identify, and then engage with DTLs. Approach, results and impact has varied. As HCP engagement dynamics continue to shift, teams are reassessing strategy and approach. How do brand teams define a path forward? Hear from Susan Abedi, Chief Strategy Officer, and Megan Fabry, EVP Digital Strategy, on real-world experiences identifying and engaging with DTLs, insights from HCP research on DTL perceptions, and guidance on how to define a DTL engagement strategy.
